Premier Alternatives

ProteoWise

New Haven, CT · Founded 2018 · Privately Held (backing)

Developer of proteomics instruments designed to enable researchers to analyze proteins easily and efficiently. ProteoWise is based in New Haven, CT and was founded in 2018. It was valued at $18 million at its later-stage round in Dec 2024, the last priced event on record. It has raised $11.8 million across 3 recorded rounds; the latest was a $2.3 million seed round in Dec 2024.

PMV mark · valuation
$18.0M
Oct 2026
Priced at
its later-stage round
Dec 2024
Total raised
$11.8M
Last round
Seed Round
Dec 2024

ProteoWise key facts

as of Oct 2026
  • Developer of proteomics instruments designed to enable researchers to analyze proteins easily and efficiently.
  • ProteoWise is valued at approximately $18.0M as of Oct 2026, set at its later-stage round, Dec 2024; nothing has traded since, per PrivateMarketView’s mark.
  • It has raised $11.8M across 3 recorded rounds; the latest was Seed Round ($2.3M) in Dec 2024.
  • Notable investors include Connecticut Innovations, Foothill Ventures, Co-Win Ventures, UniWill Ventures, Taihill Venture — 7 tracked in total.
  • ProteoWise has filed 3 Form Ds with the SEC since 2020, most recently Dec 2024 ($2.3M sold to 6 investors).
  • Status: Privately Held (backing).
PrivateMarketView mark
LOW confidence
$18.0M

Valued at $18.0M at its later-stage round, Dec 2024. Nothing has traded since.

set by its last priced roundas of Oct 2026question about this number?
Free account
More of ProteoWise with a free account
  • ·Watch ProteoWise: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

ProteoWise funding rounds

3 rounds
Dec 2024Seed Round$2.3MSEC filing▮
Mar 2021Seed Round$2.7MSEC filing▮
Mar 2020Early Stage VC$6.3MSEC filing▮
Full funding history →

ProteoWise valuation

ProteoWise was valued at $18 million at its later-stage round in Dec 2024. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has ProteoWise raised?

ProteoWise has raised $11.8 million across 3 recorded rounds since 2020. The largest was a $6.3 million early-stage round in Mar 2020; the most recent was a $2.3 million seed round in Dec 2024.

ProteoWise has filed 3 Form Ds with the SEC since 2020, most recently in Dec 2024 ($2.3 million sold to 6 investors).

ProteoWise investors

7 investors are on record for ProteoWise, including Connecticut Innovations, Foothill Ventures, Co-Win Ventures and UniWill Ventures. The seed round in Dec 2024 drew 6 investors.

About ProteoWise

Developer of proteomics instruments designed to enable researchers to analyze proteins easily and efficiently. The company offers proteomic technology that is fast, compact, cost-effective, and yields more data per sample, enabling researchers to finally move beyond blot and into easy, high-throughput bench-top proteomics.

Sector
Healthcare
HQ
New Haven, CT, United States
Founded
2018
Employees
12
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.